Skip to main content
SpringerLink
Log in

Epidemiology of Genitoanal HPV Infections and Associated Cancer

  • Chapter
  • First Online:
Sexually Transmitted Infections and Sexually Transmitted Diseases

Abstract

The etiology of cervical cancer has been successfully linked to the persistent infection with a few strains of Human Papillomavirus (HPV). The association is consistent worldwide and causality has been generally accepted, on the basis of molecular epidemiological studies, including prevalence surveys, case control studies, cohort studies to the cervical intraepithelial neoplasia (CIN) 2/3 level, and screening studies. More recently, HPV vaccination trials have consistently concluded that vaccination against HPV types 16 and 18 could virtually eliminate the occurrence of HPV 16/18-related CIN 2/3. Current research is now claiming HPV causality for other genital cancers in females and males, anal cancer, and a fraction of cancers of the oral cavity and oropharyngeal regions. Worldwide, HPV prevalence in women with normal cytology at any given point in time is approximately 10%. HPV 16 is consistently the most common viral type and HPV 18 the second with some minor regional differences. Sexual behavioral patterns across age groups and populations are central to the description of the HPV circulation and of the risk of infection. The epidemiology of HPV infections in men and its relation to male cancer is being actively investigated, with several outstanding issues in relation to sampling and testing methods.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. IARC monograph on the evaluation of carcinogenic risks to human. IARC, Lyon (1995)

    Google Scholar 

  2. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans Volume 100B. A Review of Human Carcinogens: Biological Agents IARC press (2011)

    Google Scholar 

  3. de Sanjose, S., Quint, W., Klaustenmeier, J. et al.: HPV type distribution in invasive cervical cancer: the worldwide perspective. Proceedings of the 24th International Papillomavirus Conference and Clinical Workshop, Beijing, China, 2007. Abstracts Book

    Google Scholar 

  4. Munoz, N., Bosch, F.X., Castellsague, X., et al.: Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int J Cancer 111(2), 278–285 (2004 Aug 20)

    Article  PubMed  CAS  Google Scholar 

  5. Bosch, F.X., Manos, M.M., Munoz, N., et al.: Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst 87(11), 796–802 (1995 Jun 7)

    Article  PubMed  CAS  Google Scholar 

  6. Smith, J.S., Lindsay, L., Hoots, B., et al.: Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer 121(3), 621–632 (2007 Aug 1)

    Article  PubMed  CAS  Google Scholar 

  7. Walboomers, J.M., Jacobs, M.V., Manos, M.M., et al.: Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189(1), 12–19 (1999 Sep)

    Article  PubMed  CAS  Google Scholar 

  8. Clifford, G.M., Smith, J.S., Plummer, M., Munoz, N., Franceschi, S.: Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer 88(1), 63–73 (2003 Jan 13)

    Article  PubMed  CAS  Google Scholar 

  9. Munoz, N., Bosch, F.X., de Sanjose, S., et al.: Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348(6), 518–527 (2003 Feb 6)

    Article  PubMed  Google Scholar 

  10. Castellsague, X., Diaz, M., de Sanjose, S., et al.: Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention. J Natl Cancer Inst 98(5), 303–315 (2006 Mar 1)

    Article  PubMed  Google Scholar 

  11. Carreon, J.D., Sherman, M.E., Guillen, D., et al.: CIN2 is a much less reproducible and less valid diagnosis than CIN3: results from a histological review of population-based cervical samples. Int J Gynecol Pathol 26(4), 441–446 (2007 Oct)

    Article  PubMed  Google Scholar 

  12. Khan, M.J., Castle, P.E., Lorincz, A.T., et al.: The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. J Natl Cancer Inst 97(14), 1072–1079 (2005 Jul 20)

    Article  PubMed  Google Scholar 

  13. Gravitt, P.E., Kovacic, M.B., Herrero, R., et al.: High load for most high risk human papillomavirus genotypes is associated with prevalent cervical cancer precursors but only HPV16 load predicts the development of incident disease. Int J Cancer 121(12), 2787–2793 (2007 Dec 15)

    Article  PubMed  CAS  Google Scholar 

  14. Castle, P.E., Jeronimo, J., Schiffman, M., et al.: Age-related changes of the cervix influence human papillomavirus type distribution. Cancer Res 66(2), 1218–1224 (2006 Jan 15)

    Article  PubMed  CAS  Google Scholar 

  15. Paavonen, J., Jenkins, D., Bosch, F.X., et al.: Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial. Lancet 369(9580), 2161–2170 (30 June 2007)

    Article  PubMed  CAS  Google Scholar 

  16. Plummer, M., Schiffman, M., Castle, P.E., Maucort-Boulch, D., Wheeler, C.M.: A 2-year prospective study of human papillomavirus persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion. J Infect Dis 195(11), 1582–1589 (2007 Jun 1)

    Article  PubMed  Google Scholar 

  17. De Vuyst, H., Clifford, G.M., Nascimento, M.C., Madeleine, M.M., Franceschi, S.: Prevalence and type ­distribution of human papillomavirus in carcinoma and ­intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis. Int J Cancer 124(7), 1626–1636 (1 Apr 2009)

    Article  PubMed  Google Scholar 

  18. Chiao, E.Y., Krown, S.E., Stier, E.A., Schrag, D.: A population-based analysis of temporal trends in the incidence of squamous anal canal cancer in relation to the HIV ­epidemic. J Acquir Immune Defic Syndr 40(4), 451–455 (2005 Dec 1)

    Article  PubMed  Google Scholar 

  19. Bowers, N.A., Gromada, K.K.: Pregnancy after age 35. AWHONN Lifelines 8(2), 99–100 (2004 Apr)

    Article  PubMed  Google Scholar 

  20. Kreimer, A.R., Clifford, G.M., Boyle, P., Franceschi, S.: Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev 14(2), 467–475 (2005 Feb)

    Article  PubMed  CAS  Google Scholar 

  21. Herrero, R., Castellsague, X., Pawlita, M., et al.: Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst 95(23), 1772–1783 (3 Dec 2003)

    PubMed  Google Scholar 

  22. D’Souza, G., Kreimer, A.R., Viscidi, R., et al.: Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 356(19), 1944–1956 (2007 May 10)

    Article  PubMed  Google Scholar 

  23. Gillison, M.L., D’Souza, G., Westra, W., et al.: Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst 100(6), 407–420 (2008 Mar 19)

    Article  PubMed  Google Scholar 

  24. de Sanjose, S., Diaz, M., Castellsague, X., et al.: Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis 7(7), ­453–459 (2007 Jul)

    Article  PubMed  Google Scholar 

  25. Castellsague, X., de Sanjose, S., Aguado, T., et al.: HPV and Cervical Cancer in the World. 2007 Report. WHO/ICO Information Centre on HPV and Cervical Cancer (HPV Information Centre). Vaccine 25(Suppl 3) (2007)

    Google Scholar 

  26. Franceschi, S., Herrero, R., Clifford, G.M., et al.: Variations in the age-specific curves of human papillomavirus prevalence in women worldwide. Int J Cancer 119(11), ­2677–2684 (2006 Dec 1)

    Article  PubMed  CAS  Google Scholar 

  27. Munoz, N., Mendez, F., Posso, H., et al.: Incidence, duration, and determinants of cervical human papillomavirus infection in a cohort of Colombian women with normal cytological results. J Infect Dis 190(12), 2077–2087 (15 Dec 2004)

    Article  PubMed  Google Scholar 

  28. Wellings, K., Collumbien, M., Slaymaker, E., et al.: Sexual behaviour in context: a global perspective. Lancet 368(9548), 1706–1728 (11 Nov 2006)

    Article  PubMed  Google Scholar 

  29. Chan, P.K., Cheung, T.H., Tam, A.O., et al.: Biases in human papillomavirus genotype prevalence assessment associated with commonly used consensus primers. Int J Cancer 118(1), 243–245 (1 Jan 2006)

    Article  PubMed  CAS  Google Scholar 

  30. Quint, W.G., Pagliusi, S.R., Lelie, N., de Villiers, E.M., Wheeler, C.M.: Results of the first World Health Organization international collaborative study of detection of human papillomavirus DNA. J Clin Microbiol 44(2), 571–579 (Feb 2006)

    Article  PubMed  CAS  Google Scholar 

  31. Clifford, G.M., Smith, J.S., Aguado, T., Franceschi, S.: Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis. Br J Cancer 89(1), 101–105 (7 July 2003)

    Article  PubMed  CAS  Google Scholar 

  32. De Sanjose, S., et al.: Worldwide HPV Genotype Distribution in 10,365 Cases of Cervical Cancer, 2009 p. Poster 30.13

    Google Scholar 

  33. Parkin, D., Whelan, S., Teppo, L., Thomas, D.: Cancer Incidence in Five Continents. IARC Press, Lyon (2003)

    Google Scholar 

Download references

Acknowledgment

F. Xavier Bosch’s, Xavier Castellsague’s, and Silvia de Sanjose’s work was partially supported by Spanish public grants from the Instituto de Salud Carlos III (grants RCESP C03/09, RTICESP C03/10 and RTIC RD06/0020/0095 and CIBERESP) and from the Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR 2005 SGR 00695).

The contribution of Maria Jesus Vázquez and Cristina Rajo in the preparation of the manuscript is deeply recognized.

Author information

Authors and Affiliations

  1. Unit of Infections and Cancer (UNIC), Cancer Epidemiology Research Program (CERP), Catalan Institute of Oncology (Institut Català d’Oncologia – ICO)/IDIBELL, Avda. Gran Via 199-203, 08907 L’Hospitalet de Llobregat, Barcelona, Spain

    F. Xavier Bosch, Silvia de Sanjose & Xavier Castellsagué

  2. CIBER en Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain

    Silvia de Sanjose & Xavier Castellsagué

Authors
  1. F. Xavier Bosch
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Silvia de Sanjose
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Xavier Castellsagué
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to F. Xavier Bosch .

Editor information

Editors and Affiliations

  1. Klinik und Poliklinik für, Dermatologie und Venerologie, Universitätsklinikum Rostock, Strempelstraße 13-85, Rostock, 18057, Mecklenburg-Vorpomm., Germany

    Gerd E. Gross

  2. University of Texas Health Science Cente, 451 North Texas Avenue, Houston, 77598, Texas, USA

    Stephen K. Tyring

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Berlin Heidelberg

About this chapter

Cite this chapter

Bosch, F.X., de Sanjose, S., Castellsagué, X. (2011). Epidemiology of Genitoanal HPV Infections and Associated Cancer. In: Gross, G., Tyring, S. (eds) Sexually Transmitted Infections and Sexually Transmitted Diseases. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-14663-3_33

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-14663-3_33

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-14662-6

  • Online ISBN: 978-3-642-14663-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation